Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Brain Pathology (Zurich, Switzerland)|August 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumorsPieter Wesseling, David Capper, Guido Reifenberger, et al.
Proteomics|October 21, 2014
Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinomaNazia Syed, Sandip Chavan, Nandini A Sahasrabuddhe, et al.
Proteomics|March 11, 2005
Differential protein expression in human gliomas and molecular insightsVaibhav C Chumbalkar, Chanumolu Subhashini, Vishnu M Dhople, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastomaVani Santosh, Arimappamagan Arivazhagan, Peddagangannagari Sreekanthreddy, et al.
Plos One|May 7, 2013
A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk groupArivazhagan Arimappamagan, Kumaravel Somasundaram, Kandavel Thennarasu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysisSreekanth P Reddy, Ramona Britto, Katyayni Vinnakota, et al.
Scientific Reports|June 27, 2017
Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
Scientific Reports|November 1, 2016
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinomaAneesha Radhakrishnan, Vishalakshi Nanjappa, Remya Raja, et al.
BMC Cancer|November 5, 2015
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancerTejaswini Subbannayya, Pamela Leal-Rojas, Mustafa A Barbhuiya, et al.
Pageof 16